ISU Scientists Develop Nanomachines to Diagnose Illness
July 6, 2016 | Iowa State UniversityEstimated reading time: 2 minutes
Imagine you want to build an intricate work of architecture, like a castle.
Now imagine that, once all its individual components are brought together, the castle builds itself automatically. Finally, imagine this castle is so small that it’s measured on the same scale as DNA, viruses and small molecules.
You’ve just entered the nanoscale world where Eric Henderson lives. And if this sounds like magic to you, maybe you’re not far off the mark.
“It’s the magic of how DNA works,” said Henderson, a professor of genetics, development and cell biology at Iowa State University.
Henderson, along with his former graduate student Divita Mathur, studies how to build nanomachines that may have real-world medical applications someday soon. He and Mathur recently published an article in the peer-reviewed Scientific Reports describing his laboratory’s successful effort to design a nanomachine capable of detecting a mockup of the Ebola virus.
He said such a machine would prove valuable in the developing world, where access to diagnostic medical equipment can be rare. He said his nanotechnology could be fabricated cheaply and deployed easily. Used in conjunction with a smartphone app, nearly anyone could use the technology to detect Ebola or any number of other diseases and pathogens without the need for traditional medical facilities.
The trick lies in understanding the rules that govern how DNA works, Henderson said.
“It’s possible to exploit that rule set in a way that creates advantages for medicine and biotechnology,” he said.
The iconic double-helix structure of DNA means that one strand of DNA will bind only with a complementary side. Even better, those compatible strands find each other automatically, like a castle that builds itself. Henderson harnessed those same principles for his nanomachines. The components, once added to water and then heated and cooled, find each other and assemble correctly without any further effort from the individual deploying the machines.
And just how “nano” is a nanomachine? Henderson said about 40 billion individual machines fit in a single drop of water.
The machines act as a diagnostic tool that detects certain maladies at the genetic level. For the recently published paper, Henderson and Mathur, now a postdoctoral research fellow at the Center for Biomolecular Science and Engineering at the Naval Research Laboratory in Washington, D.C., designed the machines to look for signs of Ebola, though the experiments in the study used a mock version of the viral genome and not the real thing. Henderson employed an embedded photonic system that tests for the presence of the target molecules. If the machines sniff out what they’re looking for, the photonic system flashes a light, which can be detected with a machine called a fluorometer.
Henderson said this sort of technology could be modified to find certain kinds of molecules or pathogens, allowing for virtually anyone, anywhere to run diagnostic tests without access to medical facilities.
He also envisions a time when similar nanoscale architectures could be used to deliver medication precisely where it needs to go at precisely the right time. These nanomachines, built from DNA, essentially would encapsulate the medication and guide it to its target.
Henderson said such advances aren’t that far beyond the reach of modern medicine. It just requires scientists in the field to think small. Really small, in this case.
Suggested Items
I-Connect007 Editor’s Choice: Five Must-Reads for the Week
05/02/2025 | Marcy LaRont, PCB007 MagazineIn our industry, this week’s must-read features include CEE’s Tom Yang and his perspective on having a global business amidst tariff talk and other challenges. Joe Fjelstadt talks to the “Flexperts,” Nick Koop of TTM and Mark Finstead of Flexible Circuit Technologies. Nolan Johnson interviews the McGucken Group about the importance of empathic leadership in BANI times. NCAB’s Ryan Miller writes about reliability and compliance for building PCBs for medical applications, and surprise, more news from Siemens.
Fresh PCB Concepts: Key Considerations for Reliability, Performance, and Compliance in PCBs
05/01/2025 | Team NCAB -- Column: Fresh PCB ConceptsAs a field application engineer with many years of experience, I’ve conducted thousands of designs for manufacturing (DFM) analyses on printed circuit boards (PCBs). From basic one-layer boards to complex high density interconnect (HDI) designs, I’ve provided technical advice across a wide spectrum of technologies.
Real Time with... IPC APEX EXPO 2025: Exploring LCP Materials with Matrix Electronics
04/15/2025 | Real Time with...IPC APEX EXPONolan Johnson introduces Robert Berg from Matrix Electronics, highlighting the company's focus on high-speed, low-loss flexible materials, especially LCP materials. LCP (liquid crystal polymer) is a thermal plastic with unique properties that make it ideal for advanced PCB applications. Despite processing challenges, its stability and FDA approval for medical use drive interest in aerospace and medical markets.
Flex Opens New Product Introduction (NPI) Center Serving Healthcare Customers in North America
03/25/2025 | FlexFlex announced the opening of its new product introduction (NPI) center near Boston, Mass., serving healthcare customers.
DELO Releases IBOA-free Medical Adhesive for Glucose Monitoring Sensors and Other Wearables
03/14/2025 | DELODELO has released a new light-curing medical-grade adhesive engineered with nontoxicity in mind. DELO PHOTOBOND MG4047 is designed for wearable medical applications such as glucose monitoring sensors (CGM). Its chemical properties and impermeable characteristics help prevent skin irritation in cases of media influence such as rain or sweat.Teaser